Long-Term Colon Stent Patency for Obstructing Colorectal Cancer Combined with Bevacizumab

Self-expanding metal stents can be considered as initial treatment for malignant large bowel obstruction in the palliative setting. It is suggested that systemic anti-angiogenic therapy increases the risk of stent perforation. We report a 65-year-old woman with a metastatic, obstructing colon tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Latenstein, Anouk E.J., Hendriks, Mathijs P., van Halsema, Emo E., van Hooft, Jeanin E., van Berkel, Anne-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803727/
https://www.ncbi.nlm.nih.gov/pubmed/29430222
http://dx.doi.org/10.1159/000481933
_version_ 1783298703260385280
author Latenstein, Anouk E.J.
Hendriks, Mathijs P.
van Halsema, Emo E.
van Hooft, Jeanin E.
van Berkel, Anne-Marie
author_facet Latenstein, Anouk E.J.
Hendriks, Mathijs P.
van Halsema, Emo E.
van Hooft, Jeanin E.
van Berkel, Anne-Marie
author_sort Latenstein, Anouk E.J.
collection PubMed
description Self-expanding metal stents can be considered as initial treatment for malignant large bowel obstruction in the palliative setting. It is suggested that systemic anti-angiogenic therapy increases the risk of stent perforation. We report a 65-year-old woman with a metastatic, obstructing colon tumor who has been successfully treated with stent placement and chemoimmunotherapy consisting of capecitabine and bevacizumab for 8 years.
format Online
Article
Text
id pubmed-5803727
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-58037272018-02-09 Long-Term Colon Stent Patency for Obstructing Colorectal Cancer Combined with Bevacizumab Latenstein, Anouk E.J. Hendriks, Mathijs P. van Halsema, Emo E. van Hooft, Jeanin E. van Berkel, Anne-Marie Case Rep Gastroenterol Single Case Self-expanding metal stents can be considered as initial treatment for malignant large bowel obstruction in the palliative setting. It is suggested that systemic anti-angiogenic therapy increases the risk of stent perforation. We report a 65-year-old woman with a metastatic, obstructing colon tumor who has been successfully treated with stent placement and chemoimmunotherapy consisting of capecitabine and bevacizumab for 8 years. S. Karger AG 2017-11-29 /pmc/articles/PMC5803727/ /pubmed/29430222 http://dx.doi.org/10.1159/000481933 Text en Copyright © 2017 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Single Case
Latenstein, Anouk E.J.
Hendriks, Mathijs P.
van Halsema, Emo E.
van Hooft, Jeanin E.
van Berkel, Anne-Marie
Long-Term Colon Stent Patency for Obstructing Colorectal Cancer Combined with Bevacizumab
title Long-Term Colon Stent Patency for Obstructing Colorectal Cancer Combined with Bevacizumab
title_full Long-Term Colon Stent Patency for Obstructing Colorectal Cancer Combined with Bevacizumab
title_fullStr Long-Term Colon Stent Patency for Obstructing Colorectal Cancer Combined with Bevacizumab
title_full_unstemmed Long-Term Colon Stent Patency for Obstructing Colorectal Cancer Combined with Bevacizumab
title_short Long-Term Colon Stent Patency for Obstructing Colorectal Cancer Combined with Bevacizumab
title_sort long-term colon stent patency for obstructing colorectal cancer combined with bevacizumab
topic Single Case
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803727/
https://www.ncbi.nlm.nih.gov/pubmed/29430222
http://dx.doi.org/10.1159/000481933
work_keys_str_mv AT latensteinanoukej longtermcolonstentpatencyforobstructingcolorectalcancercombinedwithbevacizumab
AT hendriksmathijsp longtermcolonstentpatencyforobstructingcolorectalcancercombinedwithbevacizumab
AT vanhalsemaemoe longtermcolonstentpatencyforobstructingcolorectalcancercombinedwithbevacizumab
AT vanhooftjeanine longtermcolonstentpatencyforobstructingcolorectalcancercombinedwithbevacizumab
AT vanberkelannemarie longtermcolonstentpatencyforobstructingcolorectalcancercombinedwithbevacizumab

Ejemplares similares